Israel Innovation Authority

Eretz Angels supports technology startups in Israel's outskirts at the start of their journey.

IR-MED LTD. is a medical device company based in Rosh Pinna, Israel, specializing in infrared light-based diagnostic systems. Founded in 2012, the company leverages advanced technologies, including big data and machine learning, to create innovative diagnostic modalities. IR-MED develops continuous and real-time monitoring devices capable of detecting and measuring various substances and pharmaceuticals in the blood. Additionally, their systems can assess fluid concentrations on surfaces and behind thin tissues, facilitating the identification and characterization of medical lesions and pathological processes in humans.

OCON Healthcare, also known as OCON Medical Ltd., specializes in developing and manufacturing innovative women's health products centered around its proprietary Intra Uterine Ball (IUB) platform. Key offerings include the IUB Ballerine, a hormone-free, copper-based intrauterine contraceptive effective for five years, and the OCON SEAD, which is currently undergoing Phase II clinical studies for treating abnormal uterine bleeding. The IUB platform, constructed from a super-elastic alloy, serves as an effective carrier for various therapeutic substances targeting conditions such as heavy menstrual bleeding, fibroids, and infertility. The company distributes its contraceptive products primarily in Europe, South Africa, and Israel. Founded in 2011, OCON Healthcare operates from its headquarters in Modi'in-Maccabim-Re'ut, Israel, and maintains an additional office in Zürich, Switzerland.

BloomX is an AI pollination solution for crops in which pollination is a limiting factor for their yield. The company allows growers to increase their revenue by enlarging yields in existing crops and improving fruit quality. BloomX's vision is to provide an AI-based pollination solution that addresses each crop’s pollination needs by mimicking the natural pollination process and enhancing it using technology. Bumblebee was founded in 2019 and is headquartered in Tel Aviv, Israel.

BioBetter is a biotechnology company that develops plant-based platforms for producing complex growth factors used in cultivated meat and for simplifying protein manufacturing and purification for biopharmaceuticals. The platform uses transgenic plants as bioreactors to express therapeutic proteins and co-expresses enzymes that remove antigenic sugars to improve protein quality and reduce production costs. By leveraging plant biology, BioBetter targets lower-cost biotech production across cultivated meat and biotech applications. The company was founded in 2015 and is headquartered in Israel.

Founded in 2015, SuperMeat is an Israeli biotech and food-tech company that produces cultured meat from chicken cells in a controlled environment. This process reduces land use by 99% and water consumption by 90%, minimizing environmental impact while ensuring food safety without antibiotics.

VALFIX Medical is a Tel Aviv-based medical device company focused on transcatheter solutions for repairing and replacing the mitral and tricuspid valves, using multi-wire technology to provide a complete transcatheter repair and replacement approach, offering an alternative to open-heart surgery and addressing heart failure symptoms by eliminating mitral regurgitation.

Enlivex Therapeutics Ltd. is a clinical-stage immunotherapy company headquartered in Nes Ziona, Israel, focused on developing allogeneic drugs aimed at rebalancing the immune system. The company's lead product, Allocetra, is an immunotherapy candidate currently undergoing multiple clinical trials. These include a Phase IIb trial for severe sepsis, an investigator-initiated Phase II trial for COVID-19 patients in severe and critical conditions, and a Phase IIa trial for preventing Graft Versus Host Disease in patients undergoing allogeneic hematopoietic stem cell transplants. Additionally, Enlivex is exploring Allocetra's potential in preventing complications from bone marrow transplants and acute multiple organ failure. The company also aims to develop cell-based therapies that enhance the efficacy of treatments for solid tumors through immune checkpoint rebalancing. Founded in 2005 by Professor Dror Mevorach, Enlivex utilizes a novel approach that focuses on inducing immune tolerance by employing apoptotic cells to modulate inflammatory and autoimmune responses.

BeeHero develops a beehive technology platform that aims to increase crop yields by enhancing pollination. The platform combines artificial intelligence, machine learning, and in-hive sensors to collect data and optimize pollination during peak cycles, helping farmers protect hives from colony collapse and maximize pollination efficiency for growers worldwide. Founded in 2017, the company operates from Tel Aviv and Silicon Valley and focuses on providing data-driven insights and automation to support pollination across agricultural environments.

Founded in 2014, ViAqua Therapeutics is based in Israel. The company specializes in developing drugs and therapeutics for aquaculture, focusing on the first orally administered treatment to prevent viral diseases.

Enlivex Therapeutics Ltd. is a clinical-stage immunotherapy company headquartered in Nes Ziona, Israel, focused on developing allogeneic drugs aimed at rebalancing the immune system. The company's lead product, Allocetra, is an immunotherapy candidate currently undergoing multiple clinical trials. These include a Phase IIb trial for severe sepsis, an investigator-initiated Phase II trial for COVID-19 patients in severe and critical conditions, and a Phase IIa trial for preventing Graft Versus Host Disease in patients undergoing allogeneic hematopoietic stem cell transplants. Additionally, Enlivex is exploring Allocetra's potential in preventing complications from bone marrow transplants and acute multiple organ failure. The company also aims to develop cell-based therapies that enhance the efficacy of treatments for solid tumors through immune checkpoint rebalancing. Founded in 2005 by Professor Dror Mevorach, Enlivex utilizes a novel approach that focuses on inducing immune tolerance by employing apoptotic cells to modulate inflammatory and autoimmune responses.

FertilAI is a healthcare company based in Israel that develops AI-driven technologies to enhance fertility treatments. Its platform, Fertilane, automates clinical decision-making processes for physicians and facilitates communication among clinics, doctors, and patients through tailored apps and web platforms.

Phytolon Ltd is a company based in Misgav, Israel, specializing in the development of natural food colorants. Founded in 2000, Phytolon utilizes a novel fermentation technology that employs baker's yeast cells as biofactories to produce high-quality, plant-based food colors. This innovative approach offers a healthy alternative to synthetic food dyes, providing food manufacturers with safe, cost-effective, and stable all-natural color solutions. The company's mission is to leverage scientific advancements to promote human health and environmental sustainability in the food industry.

Vessi Medical is an Israeli medical device startup focused on innovating treatment for Non-Muscle-Invasive Bladder Cancer (NMIBC) through a novel surface cryotherapy approach. This technique employs extreme cold to freeze and eliminate abnormal tissue, providing a minimally invasive alternative to the standard TransUrethral Resection of Bladder Tumor (TURBT), which is often inadequate and requires invasive surgery under general anesthesia. Vessi's technology, comprising a standalone console and a disposable catheter, allows for targeted cell destruction while safeguarding healthy bladder tissue. This office-based procedure not only reduces the need for costly hospital stays and repeat surgeries but also addresses the high recurrence rate of NMIBC, which affects millions globally. With promising proof of concept already demonstrated in animal studies, Vessi aims to capture the $1.2 billion NMIBC market, while also exploring future applications for treating overactive bladder and urinary tract infections. The company is supported by experienced professionals in the medical device and cryotherapy sectors, ensuring a strong foundation for its innovations.

Magentiq Eye Ltd., established in 2014, specializes in developing AI-driven medical devices for endoscopic procedures. Its flagship product is the Automatic Polyp Detection System (APDS), which uses computer vision and deep learning to assist doctors in real-time colonoscopy examinations, aiming to reduce polyp miss-rates and improve patient outcomes.

90 days from launch (Dec 20): - 4 paying clients in 90 days, 25 days sales cycle. - 10,000 users covering all 10 largest cities of Israel. Together with our SafeUPer we - Create a Safe World for Women - One community at a time. Create – We believe people must take an action, getting out of our comfort zone, to achieve this change. Sharing stories is simply not enough. Safe – We believe being safe is a basic right of all women, and like all women right achieved by previous generations, it will be gained with sweat and tears. World – We are facing a global problem, documented for at least two millennia (2,000 yrs), maybe the only problem impacting women daily, of all ages, countries, backgrounds and beliefs. Therefore. We believe it should be solved globally, empowering women all around the world to bring safety to their local communities. Women – We believe that when women will have peace, men too will have peace. Men have proven that they are unable to bring peace and safety by themselves to themselves nor to women. Therefore, we need to lead and bring it together.

DiA Imaging Analysis Ltd. is a technology company based in Beersheba, Israel, specializing in AI-powered ultrasound analysis designed to enhance the evaluation of cardiac function and other medical conditions. Founded in 2009, DiA offers a range of innovative applications, including LVivo EF for automated ejection fraction evaluation, LVivo RV for right ventricle analysis, and LVivo Strain, which assesses myocardial strain as an early indicator of reduced left ventricular function. Their tools simplify the ultrasound imaging process by providing automated analysis and optimal view selection, improving the diagnostic capabilities of clinicians. DiA's technology is compatible with various ultrasound devices and healthcare IT systems, streamlining the detection of clinical abnormalities. The company holds FDA and CE clearances and serves thousands of users globally, addressing critical challenges in ultrasound utilization by enabling more accurate and efficient image analysis through advanced pattern recognition and machine learning algorithms.

XRHealth Ltd. is a medical technology company based in Tel Aviv, Israel, that specializes in developing virtual reality (VR) software solutions for healthcare. Founded in 2016, the company offers an array of products designed to enhance patient care and treatment outcomes. Its offerings include VRPhysio, a platform for virtual physical therapy; VRReliever, which helps manage pain through distraction; VRCogni, aimed at improving motor function in stroke and dementia patients; and VRPsyc, which provides exposure therapy for various mental health disorders. Additionally, VRCoordi is designed to aid coordination recovery in patients with Parkinson's, brain injuries, and autism. By integrating immersive technologies with licensed clinicians and advanced data analytics, XRHealth provides comprehensive telehealth services, allowing patients to access treatment from the comfort of their own homes.

Enlivex Therapeutics Ltd. is a clinical-stage immunotherapy company headquartered in Nes Ziona, Israel, focused on developing allogeneic drugs aimed at rebalancing the immune system. The company's lead product, Allocetra, is an immunotherapy candidate currently undergoing multiple clinical trials. These include a Phase IIb trial for severe sepsis, an investigator-initiated Phase II trial for COVID-19 patients in severe and critical conditions, and a Phase IIa trial for preventing Graft Versus Host Disease in patients undergoing allogeneic hematopoietic stem cell transplants. Additionally, Enlivex is exploring Allocetra's potential in preventing complications from bone marrow transplants and acute multiple organ failure. The company also aims to develop cell-based therapies that enhance the efficacy of treatments for solid tumors through immune checkpoint rebalancing. Founded in 2005 by Professor Dror Mevorach, Enlivex utilizes a novel approach that focuses on inducing immune tolerance by employing apoptotic cells to modulate inflammatory and autoimmune responses.

Nobio Ltd. is a biotechnology company based in Petah Tikva, Israel, specializing in the development of innovative nano-polymer additives that provide protection against microbial infections. Its technology enables the transformation of both implantable and non-implantable devices into biofilm-resistant platforms. Nobio's product offerings include a universal bonding agent designed for strong adhesion to various dental surfaces and restorative materials, as well as flowable composites suitable for dental restorations and sealants. The core of Nobio's technology consists of potent particles embedded with highly-active antimicrobial structures that kill bacteria upon contact, effectively preventing medical device contamination indefinitely. This unique approach positions Nobio as a leader in the creation of durable antimicrobial materials and surfaces, enhancing safety and efficacy in medical and dental applications.

AgroScout Ltd. is an Israeli company established in 2017 that specializes in developing an artificial intelligence-based platform aimed at enhancing sustainable farming practices. The company's technology provides precision agriculture solutions by utilizing advanced analytics and high-resolution aerial imagery to assess crop health and monitor for pests and diseases. AgroScout's platform supports farmers by offering insights on crop emergence, stand counts, canopy coverage, and biomass throughout the growing season. This continuous monitoring allows for early detection of infestations, enabling more effective curative treatments and reducing pesticide use. By delivering actionable insights into crop management and regional outbreak predictions, AgroScout aims to improve crop yields and profitability while fostering a more sustainable food production supply chain.

Founded in 2018, Indoor Robotics designs and develops Tando, an AI-powered patrol drone for indoor security and inspection missions. Its unique features include independent AI-based navigation and patented ceiling docking, providing real-time coverage with predictive analysis to minimize false alarms.

Shamaym Improve Ltd is a company focused on enhancing organizational learning through its artificial intelligence-based platform. This platform is designed to facilitate rapid feedback and knowledge sharing among teams, drawing inspiration from the debriefing techniques utilized by the Israeli Air Force. By promoting regular debriefings, Shamaym enables teams to communicate effectively, collaborate seamlessly, and learn continuously, driving faster and more informed decision-making. The company's innovative approach leverages advanced AI and machine learning technologies to streamline lesson extraction and improve briefing processes, ultimately fostering a culture of continuous improvement in collaborative work environments.

Allerguard Ltd. is a technology company based in Tel Aviv, Israel, that specializes in personal allergy detection systems. Founded in 2017, it has developed a unique hand-held device that enables individuals with food allergies to scan their meals for allergens. Unlike traditional detection devices that require food sampling, Allerguard's system analyzes the vapors emitted by food, allowing it to detect allergen particles with precision. The device alerts users to the presence of allergens, ensuring they can make informed decisions about food consumption in real-time. This innovative approach is designed to enhance safety for those with allergies, focusing on the chemical and physical properties of specific allergens such as peanuts and tree nuts.

Yemoja Ltd. is a marine biotech company based in Upper Galilee, Israel, established in 2017. The company specializes in the sustainable production of high-value ingredients derived from microalgae for the cosmetic, food, and pharmaceutical industries. Yemoja offers a range of products, including DSkin, an extract from dunaliella salina; Algae Glow, derived from porphyridium cruentum; and EPS Glow, which features porphyridium polysaccharides. Additionally, the company produces various bioactive compounds such as astaxanthin, polysaccharides, xanthophylls, carotenoids, and enzymes with antioxidant properties. Yemoja employs state-of-the-art technology and patented processes to achieve high yields and quality standards, and it is currently expanding its production capacity by constructing a new facility designed to meet Good Manufacturing Practices (GMP).

Greeneye Technology develops AI-powered precision agriculture solutions that transform weed control by enabling real-time, selective herbicide spraying. Its proprietary selective spraying system turns standard sprayers into smart machines by detecting weeds and applying herbicides only where needed, reducing herbicide usage by up to 90%. Founded in 2017 and based in Tel Aviv, Israel, the company brings expertise across computer vision, artificial intelligence, agronomy, mechanical engineering, and spraying applications to help farmers implement sustainable, data-informed crop protection. The technology supports field insights and automated decision making to optimize spray applications, enabling farmers to lower chemical inputs while maintaining effective pest control.

RenalSense is a medical device company that develops real-time renal diagnostics and monitoring systems to detect changes in renal function and help prevent ICU-acquired acute kidney injury. Its flagship Clarity RMS system continuously measures urine flow and automatically transmits real-time data with alerts to medical staff, enabling early detection of deterioration in renal function. The company serves critical care settings and seeks to improve patient outcomes while reducing the cost of care. Founded in 2009, RenalSense is headquartered in Jerusalem and operates an office in Brookline, Massachusetts.

Enlivex Therapeutics Ltd. is a clinical-stage immunotherapy company headquartered in Nes Ziona, Israel, focused on developing allogeneic drugs aimed at rebalancing the immune system. The company's lead product, Allocetra, is an immunotherapy candidate currently undergoing multiple clinical trials. These include a Phase IIb trial for severe sepsis, an investigator-initiated Phase II trial for COVID-19 patients in severe and critical conditions, and a Phase IIa trial for preventing Graft Versus Host Disease in patients undergoing allogeneic hematopoietic stem cell transplants. Additionally, Enlivex is exploring Allocetra's potential in preventing complications from bone marrow transplants and acute multiple organ failure. The company also aims to develop cell-based therapies that enhance the efficacy of treatments for solid tumors through immune checkpoint rebalancing. Founded in 2005 by Professor Dror Mevorach, Enlivex utilizes a novel approach that focuses on inducing immune tolerance by employing apoptotic cells to modulate inflammatory and autoimmune responses.

CathWorks is a medical technology company that applies computational science platforms to enhance percutaneous coronary intervention (PCI) therapy decisions. It offers CathWorks FFRangio, a non-invasive device delivering objective multi-vessel physiologic measurements to optimize and confirm intra-procedural PCI therapies.

Founded in 2017, Soapy Care manufactures IoT-powered hygiene micro-stations designed to provide users with a precise dose of soap and water. Their smart soap capsules ensure accurate dosing for hand-washing, promoting regulatory compliance and safety.

Ramino Bio is a private biotech company that develops an oral drug to treat metabolic diseases. Ramino has received funding totaling about $3.3 million since its beginning from the FutuRx biotech incubator, which is supported by the Israeli Innovation Authority, Takeda, J&J, OrbiMed, and RMPG. By speeding up their disintegration, our exclusive technology lowers the extra BCAA that is floating around.

Convizit is an AI-driven data-as-a-service company that automatically captures and enriches user interactions from websites and SaaS applications. It records events, attaches relevant properties, and delivers structured data to analytics tools, CDPs, and marketing platforms with minimal setup. The solution eliminates the need for manual tagging or code changes, enabling fast deployment and reliable, ready-for-action behavioral data for analytics, marketing, and personalization. The company is based in Tel Aviv, Israel.

DiA Imaging Analysis Ltd. is a technology company based in Beersheba, Israel, specializing in AI-powered ultrasound analysis designed to enhance the evaluation of cardiac function and other medical conditions. Founded in 2009, DiA offers a range of innovative applications, including LVivo EF for automated ejection fraction evaluation, LVivo RV for right ventricle analysis, and LVivo Strain, which assesses myocardial strain as an early indicator of reduced left ventricular function. Their tools simplify the ultrasound imaging process by providing automated analysis and optimal view selection, improving the diagnostic capabilities of clinicians. DiA's technology is compatible with various ultrasound devices and healthcare IT systems, streamlining the detection of clinical abnormalities. The company holds FDA and CE clearances and serves thousands of users globally, addressing critical challenges in ultrasound utilization by enabling more accurate and efficient image analysis through advanced pattern recognition and machine learning algorithms.

Magentiq Eye Ltd., established in 2014, specializes in developing AI-driven medical devices for endoscopic procedures. Its flagship product is the Automatic Polyp Detection System (APDS), which uses computer vision and deep learning to assist doctors in real-time colonoscopy examinations, aiming to reduce polyp miss-rates and improve patient outcomes.

Edete Precision Technologies for Agriculture is an Israeli company specializing in automated fruit orchard pollination systems. It develops and manufactures innovative solutions for pollen harvesting, including the collection of flowers, separation of pollen from anthers, and long-term storage of pollen. The company aims to address the growing global challenge of pollination by providing efficient, mechanical pollination systems that reduce reliance on traditional insect and wind-based methods. Edete's services enhance the quantity and quality of fruit orchard yields, particularly in the face of climate change-related challenges that can disrupt natural pollination processes. Based in Basmat Tivon, Israel, the company is committed to improving agricultural outcomes for growers and companies alike through its advanced pollination technology.

MedAware develops innovative solutions using big data analytics and machine learning algorithms to analyze electronic medical records. Its patent-pending technology identifies and eliminates prescription errors in real-time, improving patient safety and reducing healthcare costs. Founded in 2012, MedAware is headquartered in Raanana, Israel.

Vectorious Medical Technologies Ltd. is a medical device company based in Tel Aviv, Israel, specializing in innovative solutions for patients with congestive heart failure. Founded in 2011, the company has developed the V-LAP, the first in-heart microcomputer designed to enhance treatment for heart failure patients by facilitating daily monitoring of left atrial pressure (LAP). This miniature wireless implant is a groundbreaking device that operates without batteries and can transmit data from deep within the body, offering a reliable means of detecting potential deterioration in heart failure. The V-LAP has been recognized as an effective predictor of heart failure worsening, thereby improving patients' quality of life and life expectancy. Vectorious is currently conducting clinical studies in various European countries, including Italy, Germany, and the UK, to obtain regulatory approval, with plans to initiate a clinical study in the United States.

Phytolon Ltd is a company based in Misgav, Israel, specializing in the development of natural food colorants. Founded in 2000, Phytolon utilizes a novel fermentation technology that employs baker's yeast cells as biofactories to produce high-quality, plant-based food colors. This innovative approach offers a healthy alternative to synthetic food dyes, providing food manufacturers with safe, cost-effective, and stable all-natural color solutions. The company's mission is to leverage scientific advancements to promote human health and environmental sustainability in the food industry.

Talenya Ltd is a technology-driven company that specializes in talent sourcing solutions. Founded in 2016 and headquartered in Rosh Haayin, Israel, with an additional office in Hoboken, New Jersey, Talenya utilizes artificial intelligence and machine learning to streamline the recruitment process. Its platform employs advanced algorithms to identify potential candidates by collecting and analyzing data from various online sources. This enables the platform to match candidate profiles with job openings effectively. Talenya's solution not only automates the talent sourcing process but also assesses and validates leads, presenting employers with qualified and diverse candidates. By empowering talent experts to establish their own recruitment practices, Talenya facilitates immediate access to both employers and suitable candidates.

SoftWheel is a technology company based in Tel Aviv, Israel, that specializes in developing advanced in-wheel suspension systems. Founded in 2011, the company focuses on enhancing personal mobility by creating innovative suspension solutions for wheelchairs, bicycles, and automobiles. SoftWheel's products include suspension arms and wheel rims, which are designed to absorb shocks and vibrations while providing rigidity and stability. The company operates through a network of resellers both domestically in Israel and internationally. It has established strategic partnerships with leading global companies such as NSK and Linamar to drive sustainable transportation and improve people’s lives through innovative technology.

Yarok Microbio is a company that specializes in advanced microbiological testing technology for the agriculture and food supply sectors. It has developed a system that significantly accelerates the detection of harmful microbes, including E. coli, Listeria, and Salmonella, providing results in just 45 minutes compared to the days required by traditional methods. This rapid testing capability addresses critical needs in the AgriFood industry, helping producers avoid costly product recalls, lawsuits, and ensuring consumer safety. The technology is versatile, applicable across various food categories, and also offers early detection of plant pathogens, which aids in the timely implementation of phytosanitary measures and reduces pesticide use. Yarok's research and development laboratory is based in Jerusalem, Israel, with a demonstration lab in Milan, Italy, to support marketing efforts in Europe. The company has received recognition for its innovative approach, including the UNIDO Innovation Award in 2017 and being named one of the Top Five Disruptors in the food technology sector by the Institute of Food Technologists in 2019.

ElastiMed develops innovative medical devices, initially focusing on smart compression therapy. Its flagship product is a wearable device using proprietary smart materials to improve leg circulation, treating Chronic Venous Insufficiency and preventing Deep Venous Thrombosis.

Augmedics is a company that develops augmented reality-guided surgical systems aimed at enhancing the safety and outcomes of surgical procedures. Founded in 2014, the company is headquartered in Yoqneam Ilit, Israel, with an additional office located in Chicago, Illinois. Its flagship product, the xvision-spine (XVS) system, features a head-mounted display that allows surgeons to visualize the patient's anatomy through skin and tissue, significantly improving their ability to navigate during complex surgeries. The system integrates real-time positioning of surgical tools and utilizes illumination to enhance the focus area, providing critical insights and assistance to surgeons throughout the procedure. Augmedics strives to revolutionize surgical treatment by leveraging advanced technology to improve healthcare delivery.

Gamida Cell Ltd., established in 1998 and headquartered in Jerusalem, Israel, is a clinical-stage biopharmaceutical company focused on developing advanced cell therapies to treat blood cancers and serious blood diseases. The company's lead product candidate, omidubicel, is an expanded hematopoietic stem cell therapy derived from umbilical cord blood, currently in Phase 3 studies for patients with high-risk hematologic malignancies and severe aplastic anemia. Additionally, Gamida Cell is developing GDA-201, a natural killer cell-based cancer immunotherapy, which is in Phase 1/2 trials for relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. Both candidates leverage the company's proprietary expansion platform based on nicotinamide to enhance cell properties and therapeutic potential.

AbiliSense Ltd., established in 2015 and headquartered in Tel Aviv-Yafo, Israel, specializes in developing sound recognition technology. The company's core product enables IoT devices to continuously monitor environmental sounds, providing real-time alerts for potential hazards or anomalies to applications, emergency call-centers, or smart devices. This innovation aims to enhance safety and security by empowering IoT devices with AI-driven smart listening capabilities.

Gamida Cell Ltd., established in 1998 and headquartered in Jerusalem, Israel, is a clinical-stage biopharmaceutical company focused on developing advanced cell therapies to treat blood cancers and serious blood diseases. The company's lead product candidate, omidubicel, is an expanded hematopoietic stem cell therapy derived from umbilical cord blood, currently in Phase 3 studies for patients with high-risk hematologic malignancies and severe aplastic anemia. Additionally, Gamida Cell is developing GDA-201, a natural killer cell-based cancer immunotherapy, which is in Phase 1/2 trials for relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. Both candidates leverage the company's proprietary expansion platform based on nicotinamide to enhance cell properties and therapeutic potential.

Nanofabrica is a pioneering company based in Tel Aviv, Israel, specializing in 3D printing technology for precision manufacturing. Founded in 2016, the company focuses on micro and nanomanufacturing, offering solutions for various sectors, including semiconductors, optics, and medical devices. Its innovative Micro Adaptive Projection technology enables the production of ultra-precise and complex parts with an unprecedented micron-resolution. This capability allows for rapid manufacturing of high-performance components, significantly reducing costs and time compared to traditional methods. By integrating advanced optics and semiconductor lithography with 3D printing, Nanofabrica serves mass customization needs, responding to customer feedback to continuously refine its technology and expand into new markets such as robotics and biomedical applications.

Atomation develops an IoT platform that connects existing devices, machines, and sensors to the internet. Its solutions enable businesses in sectors such as agriculture, medical, industrial, and logistics to gather data, draw insights, and make real-time decisions.

Catalyst AgTech Ltd. is an Israeli company focused on developing innovative technology for the agriculture sector, specifically aimed at minimizing the environmental impact of agrochemical products. The company has created a customizable technology with a self-destruction mechanism designed for use in persistent pesticides, herbicides, and fungicides. This patented catalyst technology effectively breaks down specific chemicals in fertilizers, significantly reducing their harmful effects after application and preventing groundwater contamination. By addressing the growing demand for essential pesticides while mitigating adverse environmental consequences, Catalyst AgTech offers a solution that promotes sustainable agricultural practices. The company is supported by an experienced management team and benefits from scientific collaboration with the Weizmann Institute of Science.

IR-MED LTD. is a medical device company based in Rosh Pinna, Israel, specializing in infrared light-based diagnostic systems. Founded in 2012, the company leverages advanced technologies, including big data and machine learning, to create innovative diagnostic modalities. IR-MED develops continuous and real-time monitoring devices capable of detecting and measuring various substances and pharmaceuticals in the blood. Additionally, their systems can assess fluid concentrations on surfaces and behind thin tissues, facilitating the identification and characterization of medical lesions and pathological processes in humans.